Last reviewed · How we verify

NCT04904731: DiaCOVIDProne

Effects of Body Position on Diaphragmatic Activity in Patients Requiring Noninvasive Ventilation for Acute Respiratory Failure COVID-19 Related

Completed Last updated 27 May 2021
What this trial tests

trial testing Prone position in Noninvasive Ventlation in 24 participants. Completed in 24 May 2021.

Timeline
19 February 2021
Primary endpoint
12 May 2021
24 May 2021

Quick facts

Lead sponsorAzienda Ospedaliera di Perugia
StatusCompleted
Study typeOBSERVATIONAL
Enrollment24
Start date19 February 2021
Primary completion12 May 2021
Estimated completion24 May 2021
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

Azienda Ospedaliera di Perugia — full company profile →

Who can join

18 and older, any sex, with Noninvasive Ventlation or COVID-19 Respiratory Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present investigation aims to assess the diaphragmatic thickening fraction, reflecting the diaphragmatic activity, during supine (baseline) and at 1 hour following prone position in patients assisted through non invasive ventilation due to hypoxemic acute respiratory failure related to COVID-19. Also, the impact of lung aeration and comfort were ascertained in the same setting

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Prone position

Trials testing the same drug.

Other Azienda Ospedaliera di Perugia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04904731.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing